查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1866358

心電圖（ECG）設備市場 - 全球預測（2025-2030年）

Global Electrocardiogram (ECG) Machine Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 151 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

心電圖 (ECG) 設備市場預計將從 2025 年的 73.21 億美元成長到 2030 年的 92.42 億美元，複合年成長率為 4.77%。

受心血管疾病 (CVD) 發病率上升、人口老化以及攜帶式監測技術進步的推動，全球心電圖 (ECG) 設備市場預計將呈現強勁成長。心電圖設備，包括靜態心電圖、動態心電圖和心電圖監測，能夠非侵入性記錄心臟的電活動，從而實現對異常情況的早期檢測。肥胖率上升和文明病風險增加，導致人們對持續心臟監測的需求不斷成長，這推動了市場的發展。攜帶式和家用設備等技術創新提高了監測的可近性，使患者能夠遠端監測心臟健康，從而減少了頻繁就醫的需要。主要企業的大量研發投入正在推動先進、無故障系統的開發，進一步促進市場擴張。

市場促進因素

心血管疾病發生率增加

全球心血管疾病（CVD）負擔日益加重，成為推動心電圖監測廣泛應用的成長要素，尤其是在診斷和治療方面。作為首要死因，心血管疾病凸顯了對可靠心臟評估工具的需求。這一趨勢推動了臨床和家庭環境中對心電圖設備的需求，隨著醫療機構優先考慮預防性和持續性監測以降低心臟病相關風險，心電圖設備的市場滲透率也隨之提高。

老年人口的成長

根據聯合國估計，到2050年，全球老年人口預計將達到15億，這將顯著推動市場成長。老年人罹患心臟病的風險更高，需要定期進行心電圖監測以確保及時干預。這種人口結構變化導致心臟評估數量增加，從而推動了對適用於老年人的易用型攜帶式心電圖解決方案的需求。

市場區隔與區域展望

按類型分類，心電圖監測預計將引領市場，其便攜性和在醫院外長時間連續記錄心臟活動的能力備受青睞。按終端用戶分類，醫院佔據較大佔有率，這主要得益於大量需要心電圖支持的心血管疾病相關治療和手術。按地區分類，亞太地區預計將呈現最高的複合年成長率，這主要得益於日本和印度等國家醫療基礎設施投資的增加以及人口老化。北美憑藉著成熟的醫療生態系統和主要製造商的存在，保持著顯著的市場地位。

市場限制

不利的報銷政策構成重大挑戰，因為許多保險公司和醫療機構不承保心電圖檢查，導致病人難以負擔。這種抵觸情緒可能會阻礙心電圖檢查的普及，尤其是在那些沒有全面保險的人群中，並有可能限制其在已開發市場和新興市場的市場滲透率和成長。

競爭格局

主要市場領導包括飛利浦電子、Cardiocom Solutions、Seeler AG、工業、Mortara Instruments、通用電氣和Biotelemetry。這些公司正透過推出新產品、併購策略來強化產品系列，維持競爭優勢。重點領域包括開發整合人工智慧的心電圖系統，以提高準確性和增強遠端功能。

市場展望

預計到2030年，心電圖市場將持續成長，主要驅動力包括心血管疾病（CVD）的流行、人口結構變化以及技術的便攜性。亞太地區的快速成長與北美地區長期佔據的主導地位形成鮮明對比，凸顯了家庭監測領域創新發展的機會。為了滿足日益成長的便捷心臟診斷需求，並確保在不斷變化的醫療需求中得到更廣泛的應用，行業相關人員必須透過倡導和成本最佳化策略來解決報銷障礙。

本報告的主要優勢：

  • 深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
  • 競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略打入市場的潛力。
  • 市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
  • 可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
  • 受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響

分析範圍

  • 歷史資料（2022-2024 年）和預測資料（2025-2030 年）
  • 成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
  • 競爭對手定位、策略和市場佔有率分析
  • 按業務板塊和地區（國家）分類的收入成長和預測分析
  • 公司概況（策略、產品、財務資訊、關鍵趨勢等）

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 分析範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策和法規
  • 策略建議

第4章 技術展望

5. 全球心電圖 (ECG) 設備市場（按組件分類）

  • 介紹
  • 硬體
  • 軟體
  • 服務

6. 全球心電圖 (ECG) 設備市場（按類型分類）

  • 介紹
  • 靜止心電圖
  • 攜帶式心電圖儀
  • 壓力心電圖
  • 其他

7. 全球心電圖 (ECG) 設備市場（依導極類型分類）

  • 介紹
  • 單引腳型
  • 3 引腳型
  • 6 引腳型
  • 12 線型

8. 全球心電圖 (ECG) 設備市場（依最終用戶分類）

  • 介紹
  • 醫院
  • 門診手術中心
  • 其他

9. 全球心電圖 (ECG) 設備市場（按地區分類）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 台灣
    • 其他

第10章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 企業合併、協議、商業合作
  • 競爭對手儀錶板

第11章：公司簡介

  • GE Healthcare
  • Koninklijke Philips NV
  • CardioComm Solutions, Inc
  • SCHILLER AG
  • Nihon Kohden Corporation
  • Baxter International
  • OSI System Inc.
  • Fukuda Denshi Co., Ltd.
  • Allengers
  • VectraCor

第12章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 分析方法
  • 簡稱
簡介目錄
Product Code: KSI061611215

The Electrocardiogram (ECG) Machine Market is set to increase from USD 7.321 billion in 2025 to USD 9.242 billion by 2030, at a CAGR of 4.77%.

The global electrocardiogram (ECG) machine market is poised for robust growth, driven by the escalating prevalence of cardiovascular diseases (CVDs), an aging population, and advancements in portable monitoring technologies. ECG machines, including resting ECG, stress ECG, and Holter monitors, provide non-invasive recordings of the heart's electrical activity, enabling early detection of abnormalities. The market benefits from increasing demand for continuous cardiac monitoring amid rising obesity rates and lifestyle-related risks. Technological innovations, such as handheld and home-use devices, enhance accessibility, allowing patients to monitor heart health remotely, reducing the need for frequent hospital visits. Substantial R&D investments by key players are fostering error-free, advanced systems, further propelling market expansion.

Market Drivers

Increasing Incidence of Cardiovascular Diseases

The rising global burden of CVDs is a primary growth catalyst, necessitating widespread ECG monitoring for diagnosis and management. As the leading cause of mortality, CVDs underscore the demand for reliable cardiac assessment tools. This trend amplifies the need for ECG machines in clinical and home settings, driving market adoption as healthcare providers prioritize preventive and ongoing surveillance to mitigate risks associated with heart conditions.

Expanding Geriatric Population

The global geriatric population, projected by the United Nations to reach 1.5 billion by 2050, significantly fuels market growth. Older individuals are at higher risk for cardiac issues, requiring regular ECG monitoring to ensure timely interventions. This demographic shift increases the volume of cardiac evaluations, boosting demand for user-friendly, portable ECG solutions tailored to aging populations.

Market Segments and Geographical Outlook

By type, Holter monitors are expected to dominate, valued for their portability and ability to record continuous heart activity over extended periods outside hospital environments. By end-user, hospitals hold a substantial share, driven by the high volume of CVD-related treatments and surgeries requiring ECG support. Geographically, the Asia-Pacific region is anticipated to exhibit the highest compound annual growth rate (CAGR), supported by rising investments in healthcare infrastructure and a growing geriatric demographic in countries like Japan and India. North America maintains a notable market position, bolstered by a mature healthcare ecosystem and presence of leading manufacturers.

Market Restraints

Unfavorable reimbursement policies pose a significant challenge, as many insurers and providers do not cover ECG procedures, rendering them cost-prohibitive for patients. This reluctance can deter adoption, particularly among those without comprehensive coverage, potentially limiting market penetration and growth in both developed and emerging regions.

Competitive Landscape

Key market leaders include Koninklijke Philips N.V., CardioComm Solutions, Inc., SCHILLER AG, Nihon Kohden Corporation, Mortara Instrument, General Electric Company, and BioTelemetry, Inc. These players pursue strategies such as product launches, mergers, and acquisitions to enhance their portfolios and maintain competitive advantages. Focus areas include developing integrated, AI-enhanced ECG systems for improved accuracy and remote capabilities.

Market Outlook

The ECG machine market is set for sustained expansion through 2030, propelled by CVD prevalence, demographic trends, and technological portability. Asia-Pacific's rapid growth contrasts with North America's established dominance, highlighting opportunities for innovation in home-based monitoring. Industry stakeholders must address reimbursement hurdles through advocacy and cost-optimization strategies to fully capitalize on the rising demand for accessible cardiac diagnostics, ensuring broader adoption amid evolving healthcare needs.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Market Segmentation:

By Component

  • Hardware
  • Software
  • Services

By Type

  • Resting ECG Machine
  • Portable ECG Machine
  • Stress ECG Machine
  • Others

By Lead Type

  • 1-Lead
  • 3-Lead
  • 6-Lead
  • 12-Lead

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL ELECTROCARDIOGRAM (ECG) MACHINE MARKET BY COMPONENT

  • 5.1. Introduction
  • 5.2. Hardware
  • 5.3. Software
  • 5.4. Services

6. GLOBAL ELECTROCARDIOGRAM (ECG) MACHINE MARKET BY TYPE

  • 6.1. Introduction
  • 6.2. Resting ECG Machine
  • 6.3. Portable ECG Machine
  • 6.4. Stress ECG Machine
  • 6.5. Others

7. GLOBAL ELECTROCARDIOGRAM (ECG) MACHINE MARKET BY LEAD TYPE

  • 7.1. Introduction
  • 7.2. 1-Lead
  • 7.3. 3-Lead
  • 7.4. 6-Lead
  • 7.5. 12-Lead

8. GLOBAL ELECTROCARDIOGRAM (ECG) MACHINE MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Others

9. GLOBAL ELECTROCARDIOGRAM (ECG) MACHINE MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Italy
    • 9.4.5. Spain
    • 9.4.6. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Israel
    • 9.5.4. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Thailand
    • 9.6.7. Taiwan
    • 9.6.8. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. GE Healthcare
  • 11.2. Koninklijke Philips N.V.
  • 11.3. CardioComm Solutions, Inc
  • 11.4. SCHILLER AG
  • 11.5. Nihon Kohden Corporation
  • 11.6. Baxter International
  • 11.7. OSI System Inc.
  • 11.8. Fukuda Denshi Co., Ltd.
  • 11.9. Allengers
  • 11.10. VectraCor

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key benefits for the stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations